Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.1, Iss.2, 2002-07, pp. : 121-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments on Ketolides and Macrolides

Current Medicinal Chemistry, Vol. 8, Iss. 14, 2001-12 ,pp. : 1727-1758

Bentham Science Publishers

Access to resources Recommend Favorite

A Thorough QTc Study Confirms Early Pharmacokinetics/QTc Modeling: A Supratherapeutic Dose of Omarigliptin, a Once‐Weekly DPP‐4 Inhibitor, Does Not Prolong the QTc Interval

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 5, 2016-09 ,pp. : 383-392

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Macrolides and Ketolides on Mycobacterial Infections

Current Pharmaceutical Design, Vol. 10, Iss. 26, 2004-10 ,pp. : 3221-3228

Bentham Science Publishers

Access to resources Recommend Favorite

Lomitapide at Supratherapeutic Plasma Levels Does Not Prolong the QTc Interval—Results from a TQT Study with Moxifloxacin and Ketoconazole

By Darpo Borje Ferber Georg Zhou Meijian Sumeray Mark Sager Philip

Annals of Noninvasive Electrocardiology, Vol. 18, Iss. 6, 2013-11 ,pp. : 577-589

Blackwell Publishing

Access to resources Recommend Favorite

Ketolides - The Modern Relatives of Macrolides: The Pharmacokinetic Perspective

By Zeitlinger Markus Claudia Christina Wagner Heinisch Birgit

Clinical Pharmacokinetics, Vol. 48, Iss. 1, 2009-01 ,pp. : 23-38

Adis International

Access to resources Recommend Favorite